Editorial process

What our articles are

The articles in our research-peptide guides explain what a compound is, what biological pathways researchers study it in, and how it is supplied and verified. They are research-framed: written for laboratory contexts and people deciding whether a research peptide is relevant to a study. They are not medical advice, dosing guidance, or instructions for use in humans or animals.

How they are drafted

• First drafts are produced by our editorial team with assistance from AI tools (we use Claude, by Anthropic). AI is a productivity step, not a source of truth.
• Every draft is then read and edited by a named human contributor before it is published. Articles in the Drafts queue do not appear on the public hub.
• We deliberately avoid clinical claims, dosing language, and prescriptive instructions. Where a topic is sensitive — for example legality — we mark it explicitly as YMYL and require an extra review step before publishing.

How sources are chosen

• Mechanism, structure and pathway claims are anchored to peer-reviewed literature surfaced via PubMed.
• Statements about law and regulation are anchored to the primary text published by the relevant legislature and to the responsible regulator’s own guidance — never to a secondary summary.
• Citations appear at the bottom of every article that makes a factual claim. We don’t cite our own marketing copy or unverifiable blog posts as sources.

Bylines and reviewer credit

Every article carries a named author byline. Articles on YMYL topics (Your Money or Your Life — legality, scientific claims with health implications) carry an additional reviewer credit with the reviewer’s role and credentials. Where we do not yet have a qualified named reviewer for a YMYL topic, we say so plainly rather than hide the gap behind a generic byline.

We do not invent credentials. If you read a name with a regulator number after it, that number is real and you can verify it with the regulator.

How articles are kept current

• Every article has a visible “last reviewed” date that also drives the dateModified field in our structured data.
• When the law or a referenced source changes materially, we re-review and re-date the affected articles.
• If you spot an error or a stale source, please write to us at our support form.

Commercial relationship

MY PEPTIDES is a research-grade peptide supplier. The articles describe compounds we sell. We are not impartial about the existence of these compounds — that’s the business we’re in. We are impartial about the science: a study or a statute says what it says regardless of whether we sell the related SKU.